Journal profile · Health Professions-Pharmacy
Biomedical and Biopharmaceutical Research
ISSN 2182-2360 · eISSN 2182-2379 · ALIES · Portugal
Biomedical and Biopharmaceutical Research: fully open access; no APC; review about 12 weeks (community reports); 25 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Biomedical and Biopharmaceutical Research is published by ALIES. By OpenAlex counts of its recent articles, its largest topics are Skin Protection and Aging, Advancements in Transdermal Drug Delivery and Dermatology and Skin Diseases, together about 27.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Health Professions-Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Skin Protection and AgingMedicine10.5%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics10.2%
- Dermatology and Skin DiseasesMedicine7.2%
- Medicinal Plant ResearchAgricultural and Biological Sciences6.5%
- Nutrition, Health and Food BehaviorNursing5.5%
- Cardiovascular and exercise physiologyMedicine5.2%
- Obesity, Physical Activity, DietMedicine4.2%
- Phytochemistry Medicinal Plant ApplicationsAgricultural and Biological Sciences4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacy | Q3 | 37/52 | — |
| Pharmacology (medical) | Q4 | 241/278 | — |
| General Pharmacology, Toxicology and Pharmaceutics | Q4 | 71/79 | — |
| Food Science | Q4 | 384/420 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.6LetPub ·
- SJR 2026-06
- 0.14LetPub ·
- SNIP 2026-06
- 0.16LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 14OpenAlex ·
- 2-year mean citedness
- 0.17OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 391 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 17 | 17 | 45 |
| 2025 | 25 | 25 | 71 |
| 2024 | 18 | 18 | 74 |
| 2023 | 26 | 26 | 61 |
| 2022 | 31 | 31 | 70 |
| 2021 | 21 | 21 | 66 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
- Peer review
- Double blind peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- ALIES
- Country or region
- Portugal
- Language
- English, Portuguese
- ISSN
- 2182-2360
- Electronic ISSN
- 2182-2379
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Biomedical and Biopharmaceutical Research
How long does peer review take at Biomedical and Biopharmaceutical Research?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Biomedical and Biopharmaceutical Research?
According to LetPub and DOAJ records, Biomedical and Biopharmaceutical Research is indexed in Scopus.
Is Biomedical and Biopharmaceutical Research open access, and what is the APC?
Biomedical and Biopharmaceutical Research is a fully open-access journal. It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .